Cardiovascular risk in rheumatoid arthritis and diabetes
RAID
Reporting of long-term extension studies
Treating rheumatoid arthritis to target
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
Assessing health-related quality of life in hand osteoarthritis
The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus
Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis
Prevalence of spondyloarthritis and its subtypes in southern Sweden
Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis
The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis
SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus
EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI)
Predicting the outcome of ankylosing spondylitis therapy
Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy
Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis
Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis
Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis
How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop?
Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris
Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis
Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis
Hand osteoarthritis and MRI
The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study
The prevalence and incidence of mixed connective tissue disease
Fcγ receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins
Self-management of fatigue in rheumatoid arthritis
Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases
Concepts of functioning and health important to people with systemic sclerosis
Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to other patient-reported outcomes in a register of patients with rheumatoid arthritis
Risk factors for a first thrombotic event in antiphospholipid antibody carriers
The presence of total knee or hip replacements due to osteoarthritis enhances the positive association between hand osteoarthritis and atherosclerosis in women
Zoledronic acid does not reduce MRI erosive progression in PsA but may suppress bone oedema
Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis
Early clinical response to treatment predicts 5-year outcome in RA patients
Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis
Treatment of active ankylosing spondylitis with abatacept
Differential diagnosis between rheumatoid arthritis and psoriatic arthritis
An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis
Vitamin D receptor regulates TNF-mediated arthritis
Phosphodiesterase 4 (PDE4) regulation of proinflammatory cytokine and chemokine release from rheumatoid synovial membrane
Active immunisation of human interferon α transgenic mice with a human interferon α Kinoid induces antibodies that neutralise interferon α in sera from patients with systemic lupus erythematosus
Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis
Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis
Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab
Coincidence of calcium pyrophosphate and monosodium urate crystals in the synovial fluid of patients with gout determined by the cytocentrifugation technique
Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab
Vitamin D deficiency is common in patients with RA and linked to disease activity, but circulating levels are unaffected by TNFα blockade
Hormone replacement therapy in postmenopausal women with rheumatoid arthritis stabilises bone mineral density by digital x-ray radiogrammetry in a randomised controlled trial
Variable expression and treatment of PAPA syndrome
Collagen-induced arthritis is not impaired in mast cell-deficient mice
Rituximab-treated membranous lupus nephritis
Bone metabolism is altered in preclinical rheumatoid arthritis